Literature DB >> 18271231

[The clinical observation on acupuncture at Xuanzhong (GB 39) and Ashi points for treatment of orthopedic postoperative pain].

Zhao-Hui Sun1, Cai-Xia Feng.   

Abstract

OBJECTIVE: To compare the therapeutic effects between acupuncture and Bezoxazocine injection in treatment of orthopedic postoperative pain.
METHODS: Sixty patients were randomly divided into an acupuncture group and a medication group, 30 cases in each group. The patients in the acupuncture group were treated by acupuncture at Xuanzhong (GB 39) as main point and Ashi points for 30 minutes; the medication group were treated by intramuscular injection of Bezoxazocine injection, 20 mg once, three times per day. Then the pain changes within 48 hours were observed and recorded in two groups.
RESULTS: The good rates at 24 hours and 48 hours were 89.2% and 100.0% in the acupuncture group and 81.4% and 96.3% in the medication group, respectively. The analgesic effect of acupuncture was better than that of Bezoxazocine injection (P < 0.05).
CONCLUSION: Analgesic effect of acupuncture at Xuanzhong (GB 39) on orthopedic postoperative pain and Ashi points is better than Bezoxazocine injection.

Entities:  

Mesh:

Year:  2007        PMID: 18271231

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

1.  Effectiveness of acupuncture for the treatment of postoperative pain: A protocol for a systematic review of randomized controlled trial.

Authors:  Qinhong Zhang; Jin-Huan Yue; Zhong-Ren Sun; Brenda Golianu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

2.  Therapeutic Effects of Acupuncture through Enhancement of Functional Angiogenesis and Granulogenesis in Rat Wound Healing.

Authors:  Sang In Park; Yun-Young Sunwoo; Yu Jin Jung; Woo Chul Chang; Moon-Seo Park; Young-An Chung; Lee-So Maeng; Young-Min Han; Hak Soo Shin; Jisoo Lee; Sang-Hoon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-10       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.